Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO19123 Cream in the Treatment of Atopic Dermatitis
2006-001472-20Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of calcipotriol + LEO80122 in atopic dermatitis (AD) (3 arms), sponsored by LEO Pharma. Primary endpoint: Absolute change in Total Severity Score on target area. Started Jul 2006; status: completed.
02
Drugs
calcipotriol + LEO80122
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2006-001472-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001472-20.